Gary A. Lyons, Director: Travere Therapeutics TVTX Planned sale · Filed 08/17

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Gary A. LyonsDirector
Planned sale date: 26/08/17
Filed: 26/08/17

$310.7K to be sold

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 07/18~09/16

Gary A. Lyons's recent trades

Gary A. LyonsDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$317.7K
5,000 sh
$317.7K
Filed 08/18
Traded 08/18
Gary A. LyonsDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$328.6K
8,000 sh
$328.6K
Filed 04/16
Traded 04/14
Gary A. LyonsOfficer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$245.6K
8,000 sh
$245.6K
Filed 04/14
Traded 04/14
Gary A. LyonsDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$2.3M
15,000 sh
$2.3M
Filed 25/12/04
Traded 25/12/03
Gary A. LyonsDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$2.3M
15,000 sh
$2.3M
Filed 25/12/03
Traded 25/12/03

Gary A. Lyons, Director — plans to sell 5,000 sh of Travere Therapeutics TVTX · $310.7K · around 08/17 · 10b5-1 plan | Whalegun